|
English
|
正體中文
|
简体中文
|
Total items :0
|
|
Visitors :
52879909
Online Users :
683
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
|
|
|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"hsu c"
Showing items 491-500 of 881 (89 Page(s) Totally)
<< < 45 46 47 48 49 50 51 52 53 54 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2020-08-06T07:51:44Z |
Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma
|
Yu C.-W.; Liang P.-C.; Hsu C.; Hsu C.-H.; Cheng A.-L.; TIFFANY TING-FANG SHIH; Hsu C.-Y.; Chen B.-B. |
| 臺大學術典藏 |
2020-07-10T08:16:43Z |
Using standardised measures of health-related quality of life: Critical issues for users and developers
|
Kind, P.;Hsu, C.;Wang, J.-D.;Yao, G.;Tang, J.-L.; Kind, P.; Hsu, C.; Wang, J.-D.; Yao, G.; Tang, J.-L.; KAI-PING GRACE YAO |
| 臺大學術典藏 |
2020-07-09T02:57:04Z |
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
|
Hsu C.-H.; Chen B.-B.; Wei S.-Y.; Cheng A.-L.; Shih T.T.-F.; Hsu C.-Y. ;Shen Y.-C. ;Chih-Wei Yu ;Hsu C. ;Hu F.-C. ;Hsu C.-H. ;Chen B.-B. ;Wei S.-Y. ;Cheng A.-L. ;Shih T.T.-F.; Hsu C.-Y.; Shen Y.-C.; CHIH-WEI YU; Hsu C.; Hu F.-C. |
| 臺大學術典藏 |
2020-07-09T02:57:03Z |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
CHIH-WEI YU; Hwang W.-S.; Hsieh T.-Y.; Huang W.-T.; Chao Y.; Meng R.; Cheng A.-L.; Hsieh R.-K.; Huo T.-I.; Yang T.-S.; Hsu C. |
| 臺大學術典藏 |
2020-07-09T02:57:02Z |
Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: Comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy
|
Chen B.-B.; Hsu C.-Y.; CHIH-WEI YU; Liang P.-C.; Hsu C.; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2020-07-09T02:57:01Z |
Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma
|
Chen B.-B.;Hsu C.-Y.;Chih-Wei Yu;Liang P.-C.;Hsu C.;Hsu C.-H.;Cheng A.-L.;Shih T.T.-F.; Chen B.-B.; Hsu C.-Y.; CHIH-WEI YU; Liang P.-C.; Hsu C.; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2020-07-03T08:45:47Z |
Induction of DNA damage-inducible gene GADD45�] contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells
|
Chen K.-F; Yu S.-L; Da-Liang Ou;Shen Y.-C;Yu S.-L;Chen K.-F;Yeh P.-Y;Fan H.-H;Feng W.-C;Wang C.-T;Lin L.-I;Hsu C;Cheng A.-L.; DA-LIANG OU; Shen Y.-C; Yeh P.-Y; Fan H.-H; Feng W.-C; Wang C.-T; Lin L.-I; Hsu C; Cheng A.-L. |
| 臺大學術典藏 |
2020-07-03T08:45:44Z |
Growth arrest dna damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma
|
Feng Z.-R; Liou J.-Y; Fan H.-H; Lee B.-S; Hsu C; Cheng A.-L.Ann-Lii; Lin L.-I; Shyue S.-K; Da-Liang Ou;Shyue S.-K;Lin L.-I;Feng Z.-R;Liou J.-Y;Fan H.-H;Lee B.-S;Hsu C;Cheng A.-L.Ann-Lii; DA-LIANG OU |
| 臺大學術典藏 |
2020-07-03T08:45:42Z |
Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy
|
Shao Y.-Y;Chen B.-B;Da-Liang Ou;Lin Z.-Z;Hsu C.-H;Wang M.-J;Cheng A.-L;Hsu C.; Shao Y.-Y; Chen B.-B; DA-LIANG OU; Lin Z.-Z; Hsu C.-H; Wang M.-J; Cheng A.-L; Hsu C. |
| 臺大學術典藏 |
2020-07-03T08:45:42Z |
Simultaneous visualization of the subfemtomolar expression of microRNA and microRNA target gene using HILO microscopy
|
Lin Y.-Z;Da-Liang Ou;Chang H.-Y;Lin W.-Y;Hsu C;Chang P.-L.; Lin Y.-Z; DA-LIANG OU; Chang H.-Y; Lin W.-Y; Hsu C; Chang P.-L. |
Showing items 491-500 of 881 (89 Page(s) Totally)
<< < 45 46 47 48 49 50 51 52 53 54 > >>
View [10|25|50] records per page
|
